Becker's Oncology

The FDA has approved eight oncology indications since Sept. 9. These include label expansions for bladder, colon and breast cancer, and two drugs now approved for previously untreated patients with leukemia and lung cancer. Here are eight recent oncology drug…

Merck CEO Rob Davis expects the personalized cancer vaccine the company is developing with Moderna to become faster to manufacture over time, according to an Oct. 14 CNBC report. The current turnaround is about six weeks, from sequencing a patient’s…

Miami-based Baptist Health Herbert Wertheim Cancer Institute has appointed Michael Walsh, MD, deputy director of Baptist Health Cancer Care.  Dr. Walsh will also serve as chief of the Herbert Wertheim Center for Cancer Prevention, according to an Oct. 12 news…

Mortality declines for many childhood cancers have slowed since the mid-1990s, and few new cancer drugs are being developed for children, according to the “Pediatric Cancer Landscape 2026” report published Sept. 29. The report — a joint effort between the…

The Mark Foundation for Cancer Research has selected four multi-institutional teams to receive Endeavor Awards totaling $12 million. Each team, comprising researchers from 11 academic institutions across five countries, will receive $3 million over three years, according to an Oct.…